Rang	Name	Position
1	Mr. David Moatazedi	President, CEO & Director
2	Ms. Tatjana Mitchell	Chief Financial Officer
3	Dr. Rui Avelar C.CFP, Dip.SportMed, M.D.	Chief Medical Officer and Head of Research & Development
4	Mr. Nareg Sagherian	Head of Global Investor Relations & Corporate Communications
5	Mr. Kurt Knab	Senior Vice President of Sales
6	Ms. Jessica Novak	Senior Vice President of Human Resources
7	Mr. Jeffrey J. Plumer	Corporate Secretary

Aufteilung der Investoren

Rang	Inhaber	Anteile	Wert
1	Nantahala Capital Management, LLC	9,65%	49,99 Mio. USD
2	BlackRock Inc	6,50%	33,64 Mio. USD
3	BRAIDWELL LP	4,70%	24,35 Mio. USD
4	Frazier Life Sciences Management, L.P.	3,98%	20,62 Mio. USD
5	Vanguard Capital Management, LLC	3,74%	19,37 Mio. USD
6	Perceptive Advisors LLC	3,72%	19,28 Mio. USD
7	Millennium Management LLC	2,71%	14,02 Mio. USD
8	Stonepine Capital Management Llc	2,66%	13,79 Mio. USD
9	Pinnacle Associates Inc	2,25%	11,66 Mio. USD
10	Armistice Capital, LLC	2,11%	10,94 Mio. USD
11	Geode Capital Management, LLC	2,09%	10,83 Mio. USD
12	State Street Corp	2,00%	10,36 Mio. USD
13	Rice Hall James & Associates, LLC	1,95%	10,11 Mio. USD
14	AWH Capital, L.P.	1,89%	9,80 Mio. USD
15	The Goldman Sachs Group Inc	1,64%	8,52 Mio. USD
16	Assenagon Asset Management SA	1,38%	7,12 Mio. USD
17	Soleus Capital Management, L.P.	1,25%	6,45 Mio. USD
18	Soviero Asset Management, LP	1,17%	6,04 Mio. USD
19	UBS Group AG	1,14%	5,90 Mio. USD
20	Charles Schwab Investment Management Inc	0,78%	4,04 Mio. USD